Combining Targeted Therapy With Immunotherapy inBRAF-Mutant Melanoma: Promise and Challenges

Journal of Clinical Oncology - United States
doi 10.1200/jco.2013.52.1377
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Combining Immunotherapy With Oncogene-Targeted Therapy: A New Road for Melanoma Treatment

Frontiers in Immunology
AllergyImmunology
2015English

Targeted Therapy and Immunotherapy: Emerging Biomarkers in Metastatic Melanoma

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2020English

Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma

Frontiers in Immunology
AllergyImmunology
2019English

Comparative Efficacy of Combination Immunotherapy and Targeted Therapy in the Treatment of BRAF-mutant Advanced Melanoma: A Matching-Adjusted Indirect Comparison

Immunotherapy
OncologyAllergyImmunology
2019English

Combining Immunotherapy With Radiation Therapy in Thoracic Oncology

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

Strong Emerging Rationale for Combining Oncogene-Targeted Agents With Immunotherapy

OncoImmunology
OncologyAllergyImmunology
2013English

Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Clinical Opportunities in Combining Immunotherapy With Radiation Therapy

Frontiers in Oncology
Cancer ResearchOncology
2012English

EGFR-targeted Cancer Therapy: Promise, Problems and Potential Solutions

Translational Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy